Palomaki G - Search Results

1

Genetic test evaluation: information needs of clinicians, policy makers, and the public.

Burke W, Atkins D, Gwinn M, Guttmacher A, Haddow J, Lau J, Palomaki G, Press N, Richards CS, Wideroff L, Wiesner GL. Burke W, et al. Among authors: palomaki g. Am J Epidemiol. 2002 Aug 15;156(4):311-8. doi: 10.1093/aje/kwf055. Am J Epidemiol. 2002. PMID: 12181100 Review.

2

Analytic validity of cystic fibrosis testing: a preliminary estimate.

Palomaki GE, Bradley LA, Richards CS, Haddow JE. Palomaki GE, et al. Genet Med. 2003 Jan-Feb;5(1):15-20. doi: 10.1097/00125817-200301000-00003. Genet Med. 2003. PMID: 12544471 Free article.

3

Assessing the analytic validity of molecular testing for Huntington disease using data from an external proficiency testing survey.

Palomaki GE, Richards CS. Palomaki GE, et al. Genet Med. 2012 Jan;14(1):69-75. doi: 10.1038/gim.0b013e3182310bb5. Epub 2011 Sep 26. Genet Med. 2012. PMID: 22237433 Free article.

4

Nicked free beta-subunit and Down syndrome screening.

Palomaki GE, Haddow JE. Palomaki GE, et al. Am J Obstet Gynecol. 1996 Oct;175(4 Pt 1):1075. doi: 10.1016/s0002-9378(96)80056-1. Am J Obstet Gynecol. 1996. PMID: 8885779 No abstract available.

5

Estimated analytic validity of HFE C282Y mutation testing in population screening: the potential value of confirmatory testing.

Palomaki GE, Haddow JE, Bradley LA, Richards CS, Stenzel TT, Grody WW. Palomaki GE, et al. Genet Med. 2003 Nov-Dec;5(6):440-3. doi: 10.1097/01.gim.0000096500.66084.85. Genet Med. 2003. PMID: 14614395

6

Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: public health implications.

McClain MR, Palomaki GE, Nathanson KL, Haddow JE. McClain MR, et al. Genet Med. 2005 Jan;7(1):28-33. doi: 10.1097/01.gim.0000151155.36470.ff. Genet Med. 2005. PMID: 15654225

7

Results from an external proficiency testing program: 11 years of molecular genetics testing for myotonic dystrophy type 1.

Richards CS, Palomaki GE, Hegde M. Richards CS, et al. Genet Med. 2016 Dec;18(12):1290-1294. doi: 10.1038/gim.2016.59. Epub 2016 Jun 2. Genet Med. 2016. PMID: 27253733 Free article.

8

Confusion between analytic validity and clinical validity.

Palomaki GE, Haddow JE. Palomaki GE, et al. Am J Obstet Gynecol. 2016 Oct;215(4):533-4. doi: 10.1016/j.ajog.2016.06.008. Epub 2016 Jun 15. Am J Obstet Gynecol. 2016. PMID: 27316786 No abstract available.

9

Age-related prevalence of down syndrome.

Palomaki GE, Haddow JE. Palomaki GE, et al. Am J Obstet Gynecol. 1999 Jun;180(6 Pt 1):1597-8. doi: 10.1016/s0002-9378(99)70063-3. Am J Obstet Gynecol. 1999. PMID: 10368552 No abstract available.

10

Down's syndrome screening.

Haddow JE, Palomaki GE. Haddow JE, et al. Among authors: palomaki ge. Lancet. 1996 Jun 8;347(9015):1625; author reply 1625-6. Lancet. 1996. PMID: 8667893 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters